SAMMARELLI, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 1.776
EU - Europa 1.643
AS - Asia 758
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
OC - Oceania 2
Totale 4.186
Nazione #
US - Stati Uniti d'America 1.737
CN - Cina 614
IE - Irlanda 351
SE - Svezia 343
FI - Finlandia 295
UA - Ucraina 208
DE - Germania 194
IT - Italia 141
TR - Turchia 68
GB - Regno Unito 49
IN - India 44
CA - Canada 39
BE - Belgio 17
AT - Austria 15
SG - Singapore 15
IR - Iran 12
RO - Romania 9
RU - Federazione Russa 7
EU - Europa 5
NL - Olanda 5
FR - Francia 4
ES - Italia 2
MD - Moldavia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BN - Brunei Darussalam 1
CM - Camerun 1
HK - Hong Kong 1
HR - Croazia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 4.186
Città #
Chandler 401
Dublin 351
Jacksonville 226
Beijing 154
Dearborn 137
Ashburn 134
Nanjing 101
Ann Arbor 76
Parma 73
Princeton 65
San Mateo 57
Izmir 56
Pune 40
Boardman 39
Wilmington 37
Toronto 35
Bremen 34
Shanghai 34
Kunming 33
Jinan 31
New York 31
Nanchang 30
Shenyang 30
Helsinki 27
Hebei 25
Woodbridge 24
Düsseldorf 23
Hefei 19
Tianjin 18
Brussels 17
Changsha 17
Jiaxing 16
Grafing 15
Vienna 15
Norwalk 13
Des Moines 12
Hangzhou 12
Auburn Hills 10
Kocaeli 10
Zhengzhou 10
Chengdu 8
Focsani 7
Fremont 7
Guangzhou 7
Leawood 7
Los Angeles 7
West Jordan 6
Fuzhou 5
Houston 5
Mestre 5
Ningbo 5
Bologna 4
Fairfield 4
Lanzhou 4
Modena 4
Augusta 3
Borås 3
Cesena 3
Reggio Emilia 3
Rockville 3
Seattle 3
Torrile 3
Wuhan 3
Amsterdam 2
Chisinau 2
Edinburgh 2
Haikou 2
Leytonstone 2
Madrid 2
Milan 2
Orange 2
Piacenza 2
Redwood City 2
Sabz 2
Taizhou 2
Timisoara 2
Washington 2
Wenzhou 2
Zanjan 2
Andover 1
Ardabil 1
Auckland 1
Bandar Seri Begawan 1
Baotou 1
Boston 1
Bradford 1
Brescia 1
Castel San Giovanni 1
Catania 1
Chaoyang 1
Charlotte 1
Chicago 1
Denver 1
Domodedovo 1
Dubai 1
Gatchina 1
Henderson 1
Huizen 1
Jinhua 1
Lagos 1
Totale 2.650
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 111
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 97
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 97
Clinical case of polyglandural autoimmune sindrome II and hypopituitarism 96
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 96
Are the Myeloma bone microevironment cells tumoral or not? 93
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 89
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 86
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 84
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 83
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 82
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 80
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 80
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 79
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 78
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 77
Modulation of non canonical wnt5a/ror2 signaling pathway in human mesenchymal cells increases osteogenic differentiation counterbalancing the effect of myeloma cells 76
IL-7 is produced by myeloma cells in presence of IL-6 73
Diagnosi di maschio XX nel corso di screening di candidati alla fecondazione assistita mediante ICSI (Intracytoplasmatic Sperm Injection) 72
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 71
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 69
Multiple myeloma patient with unusual extramedullary involvement 68
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 68
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients 68
Osteopontin is produced by human multiple myeloma cells 67
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 67
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 66
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 66
Angiogenic properties of human myeloma cells: role of angiopoietin system 65
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 64
Basic fibroblast growth factor (bFGF) production and role in multiple myeloma patients 64
Analysis of lineage involvement in Philadelphia chromosome positive acute lymphoblastic leukemia 64
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 64
Isochromosome for derivative 17q- in two cases of acute promyelocytic leukemia 61
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 61
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia. Haematologica 60
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 60
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 60
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 59
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations 59
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 57
Relationship between bone imaging features and bone marrow cytokine and chemokine profiles in patients with monoclonal gammopathy 57
Role of receptor activator of NF-kB ligand (RANKL) in the physiopathology of multiple myeloma 55
Expression and role of chemokine receptor CXCR3 in multiple myeloma 55
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 54
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 53
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 52
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients 52
Human myeloma cells stimulate the receptor activator of NF-kB ligand (RANKL) in T cells: role of interleukin-7 52
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 51
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 50
Expression of pro-angiogenetic factors by myeloma cells: role of the angiopoietin system 50
Relationship between presence of osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: role of chemokine (C-C motif) ligand 20 50
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 49
Pericentric inversion of chromosome 9 in myeloproliferative and myelodysplastic syndromes 49
Relationship between skeletal involvement, cytogenetic features and bone marrow profiles of cytokines and chemokines in patients with monoclonal gammopathy 48
Role of 1q21 in multiple myeloma: From pathogenesis to possible therapeutic targets 48
Effects of the tyrosine inhibitor AG 957 and an anti-Fas receptor antibody on CD34+ chronic myelogenous leukemia progenitor cells 47
Human myeloma cells produce angiopoietin-1: potential relationship with myeloma-induced angiogenesis 47
RANKL is critically involved in the physiopathology of multiple myeloma 46
Pro-angiogenetic properties of myeloma cells: role in myeloma-induced angiogenesis 42
PML is required for telomere stability in non-neoplastic human cells 37
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations 35
Erratum: PML is required for telomere stability in non-neoplastic human cells (Oncogene (2016) 35 (1811-1821) DOI: 10.1038/onc.2015.246) 34
The impact of CD56 expression in smoldering myeloma patients on early progression 29
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 28
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 18
Selective expression and constitutive phosphorylation of Src-homology-2 and collagen-homology domains proteins in the CD34(+) fraction of chronic myelogenous leukemias 16
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 5
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 4
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 4
Totale 4.254
Categoria #
all - tutte 12.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019105 0 0 0 0 0 0 0 0 0 3 76 26
2019/2020866 141 162 48 19 63 101 105 17 67 68 25 50
2020/2021476 35 54 43 4 57 4 47 10 113 21 81 7
2021/2022325 5 5 4 20 5 18 37 52 14 22 49 94
2022/20231.444 149 152 100 111 160 160 38 89 431 7 36 11
2023/2024446 25 61 11 20 35 129 71 58 18 18 0 0
Totale 4.254